Pt. #, age, sex | Underlying disease | Date of TX | Type of TX | Onset of PTLD | Immuno suppressive treatment (dosage) | PTLD description | EBV DNA copies/105PBMC |
---|---|---|---|---|---|---|---|
1, 29, M | cystic fibrosis | Dec. 2000 | double-lung | May 2003 | Ciclosporin (350 mg/die) Steroid (5 mg/die) | Laterocervical HL | 1,760 |
2, 25, F | cystic fibrosis | Sep. 2001 | double-lung | May 2002 | Ciclosporin (150 mg/die) Steroid (40 mg/die) | Mediastinic large B-cells NHL | < 10 |
3, 53, M | sarcoidosis | Dec. 2001 | single-lung | Nov. 2002 | Ciclosporin (250 mg/die) Steroid (25 mg/die) | Mediastinic large B-cells NHL | < 10 |
4, 39, M | Istiocytosis X | Dec. 2004 | double-lung | May 2005 | Ciclosporin (550 mg/die) Steroid (5 mg/die) | thoracic localization of EBV-positive B-cell lymphoma. | 307 |
5, 63, M | Idiopathic pulmonary fibrosis | Aug. 2006 | double-lung | Dec. 2006 | Ciclosporin (300 mg/die) Steroid (20 mg/die) Mycophenolate mofetil (1000 mg/die) | Single nodule in lower left lobe, double mediastinic nodule (at histology, no tumor markers) 751,000 EBV DNA copies/μg tissue DNA, 8,500,000 copies/ml BAL | 15, 289 |